# The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF

> **NCT06973902** · — · RECRUITING · sponsor: **Quovadis Associazione** · enrollment: 120 (estimated)

## Conditions studied

- Symptomatic Congestive Heart Failure

## Interventions

- **DEVICE:** Cardiac Contractility Modulation (CCM) implant

## Key facts

- **NCT ID:** NCT06973902
- **Lead sponsor:** Quovadis Associazione
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973902, "The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06973902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*